Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17697-46-0

17697-46-0

Post Buying Request

17697-46-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17697-46-0 Usage

Synthesis Reference(s)

Journal of the American Chemical Society, 72, p. 2978, 1950 DOI: 10.1021/ja01163a047

Check Digit Verification of cas no

The CAS Registry Mumber 17697-46-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,6,9 and 7 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 17697-46:
(7*1)+(6*7)+(5*6)+(4*9)+(3*7)+(2*4)+(1*6)=150
150 % 10 = 0
So 17697-46-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H18N2O2/c1-9(2,11(12)13)8-10-6-4-3-5-7-10/h3-8H2,1-2H3

17697-46-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2-methyl-2-nitropropyl)piperidine

1.2 Other means of identification

Product number -
Other names 1-Piperidyl-2-methyl-2-nitropropan

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17697-46-0 SDS

17697-46-0Relevant articles and documents

-

Snyder,Hamlin

, p. 5082 (1950)

-

-

Belikov,V.M. et al.

, p. 1199 - 1216 (1970)

-

NOVEL C28-ANALOGUES WITH C3-MODIFICATIONS OF TRITERPENE DERIVATIVES AS HIV INHIBITORS

-

Page/Page column 35, (2017/03/08)

The present invention relates to compounds of novel C28-analogues with C3- modifications of triterpene derivatives of formula (I); or pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable hydrates, tautomers, stereoisomers, prodrugs, compositions or combination thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, X, and Z are as defined herein. The present invention also relates to pharmaceutical compositions comprising compounds of formula (I) useful for the treatment of viral diseases and particularly HIV mediated diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17697-46-0